Ophthalmology
We are on a mission to save and restore eyesight. By carrying out cutting-edge research and leading pioneering breakthroughs, we continually learn and refine our approach to support people living with preventable vision loss, redefining what is possible for people.
:quality(90)/)
Challenge
A global and individual burden
Over 330 million people around the world are blind or living with vision loss.1 While the annual global productivity loss from vision impairment is estimated to be over US$400 billion.2
But the cost to the individual is far greater. Losing your sight can feel like losing your greatest connection to the world – to the people you love and the future you once saw for yourself. The challenges in preventable vision loss are urgent and expanding; they demand more than small steps, requiring transformative innovation that changes the way care looks.
Focus
A comprehensive and purposeful approach
Our treatments have helped millions of people across more than 100 countries, having a profound impact on communities worldwide. To expand the impact we can have, our comprehensive ophthalmology pipeline reimagines what’s medically possible. By integrating novel targets, advanced delivery systems, and diverse technologies such as cell and gene therapies, we operate with the ultimate ambition of not only preserving sight, but aiming to restore it.
Powered by technology and collaboration
We don’t work in isolation; we are proud to be part of the ophthalmology community and we are here to stay. We continually leverage imaging, biomarker, and genetic capabilities - augmented by AI - as vital tools to interrogate data and push forward innovation. By working closely with specialists, listening to the real-world needs of patients, and collaborating across healthcare systems, we feed these insights back into early research. This ensures our pipeline addresses real needs, establishing a positive feedback loop of purposeful innovation that helps people stay in control of their future and embrace a life of possibilities.
References
Bourne R, Steinmetz JD, Flaxman S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e130-e143. doi:10.1016/S2214-109X(20)30425-3
Bassett H, Faal H, Burton M. The Lancet Global Health Commission on Global Eye Health: key findings. Community Eye Health. 2021;34(111)
Meet Ophthalmology team
:quality(90)/)
:quality(90)/)
:quality(90)/)
![[Quote] We partner with leading ophthalmology experts globally to develop innovative solutions that could transform the diagnosis and treatment experience for people living with vision loss.](https://assets.roche.com/f/176343/5335x3001/2cfddafdee/1157710-1-031-ophtha-wsd-roche-com-images-2021-12-09-v8-ah_stefan-scheidl.png/m/320x180/filters:format(webp):quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)